|By PR Newswire||
|January 28, 2014 03:15 PM EST||
IPSWICH, Mass., Jan. 28, 2014 /PRNewswire/ -- NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs (NEB®), offers bench-side support for molecular biology experimental planning. Boasting improved algorithms and a more intuitive interface, NEBioCalculator supports several commonly-used biomath needs, such as molarity calculation, OD260 conversion, ligation calculation, and mass/moles conversion for both dsDNA and ssRNA. NEBioCalculator joins the growing selection of online tools and Apple® and Android™ apps from NEB, which include the popular NEB Tools, Double Digest Finder and Enzyme Finder, as well as NEBuilder®, NEBaseChanger™, and its Tm Calculator.
Unlike other web-based conversion tools, NEBioCalculator provides calculations based on user-specified units, rather than a "one size fits all" single-unit model. Scientists can input their measurements in milligram, microgram, nanogram or picogram amounts, leading to accurate calculations that require no further conversion.
"Our customers can educate themselves on an application, identify reagents needed, and design their experiments – all while visiting NEB's website," said Tanya Osterfield, Manager of Digital Marketing at NEB. "NEBioCalculator is a useful tool that will help improve our customers' user experience, as we strive to provide unmatched scientific and technical support to our customers."
NEBioCalculator was developed as a part of NEB's cloning educational campaign, which includes new animations about the various types of cloning workflows, and special rewards for purchasing NEB cloning products. For more information on this campaign, visit CloneWithNEB.com.
NEBioCalculator is available online, at NEBioCalculator.neb.com
About New England Biolabs Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
NEW ENGLAND BIOLABS®, NEB®, and NEBUILDER® are registered trademarks of New England Biolabs, Inc.
NEBIOCALCULATOR™ and NEBASECHANGER™ are trademarks of New England Biolabs, Inc.
APPLE® is a registered trademark of Apple, Inc.
ANDROID™ is a trademark of Google, Inc.
SOURCE New England Biolabs
Aug. 25, 2016 10:45 PM EDT Reads: 1,855
Aug. 25, 2016 10:15 PM EDT Reads: 1,706
Aug. 25, 2016 09:15 PM EDT Reads: 2,187
Aug. 25, 2016 09:00 PM EDT Reads: 1,691
Aug. 25, 2016 08:45 PM EDT Reads: 1,371
Aug. 25, 2016 06:30 PM EDT Reads: 1,918
Aug. 25, 2016 05:15 PM EDT Reads: 646
Aug. 25, 2016 04:15 PM EDT Reads: 435
Aug. 25, 2016 03:30 PM EDT Reads: 1,492
Aug. 25, 2016 03:15 PM EDT Reads: 2,216
Aug. 25, 2016 02:00 PM EDT Reads: 3,547
Aug. 25, 2016 01:00 PM EDT Reads: 3,892
Aug. 25, 2016 01:00 PM EDT Reads: 2,596
Aug. 25, 2016 12:45 PM EDT Reads: 592
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
Aug. 25, 2016 12:15 PM EDT Reads: 3,387